Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Assets Average: 2011-2019

Historic Assets Average for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Mar 2019 value amounting to $80.0 million.

  • EyePoint Pharmaceuticals' Assets Average rose 148.66% to $80.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $80.0 million, marking a year-over-year increase of 148.66%. This contributed to the annual value of $45.2 million for FY2018, which is 79.63% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Assets Average of $80.0 million as of Q1 2019, which was down 4.19% from $83.5 million recorded in Q4 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Assets Average registered a high of $83.5 million during Q4 2018, and its lowest value of $13.8 million during Q4 2017.
  • For the 3-year period, EyePoint Pharmaceuticals' Assets Average averaged around $44.8 million, with its median value being $32.2 million (2018).
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 46.62% in 2017, then spiked by 506.83% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Assets Average stood at $25.7 million in 2015, then dropped by 13.09% to $22.3 million in 2016, then tumbled by 38.40% to $13.8 million in 2017, then skyrocketed by 506.83% to $83.5 million in 2018, then skyrocketed by 148.66% to $80.0 million in 2019.
  • Its Assets Average was $80.0 million in Q1 2019, compared to $83.5 million in Q4 2018 and $80.3 million in Q3 2018.